Obesity and Its Relationship to Adverse Cardiovascular Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction in the I-PRESERVE Trial

被引：0

作者：

Kitzman, Dalane W. ^{[1
]}

Haas, Marcus M. ^{[2
]}

Carson, Peter E. ^{[3
,4
]}

Hetzel, Scott ^{[5
]}

Komajda, Michael ^{[6
,7
]}

Zile, Michael ^{[8
,9
]}

Mckelvie, Robert ^{[10
]}

Mcmurray, John J. ^{[11
]}

Demets, D. ^{[5
]}

Staiger, C. ^{[13
]}

Ptaszynska, Agata ^{[12
]}

Massie, Barry ^{[14
,15
]}

机构：

[1] Wake Forest Univ Hlth Sci, F-75634 Winston Salem, NC USA

[2] Theresienkrankenhaus, Mannheim, Germany

[3] Washington VAMC, Washington, DC 29425 USA

[4] Georgetown Univ, Washington, DC USA

[5] Univ Wisconsin, Madison, WI USA

[6] Univ Paris 06, Paris, France

[7] Grp Hosp Pitie Salpetriere, Paris, France

[8] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA

[9] Med Univ S Carolina, Charleston, SC 94143 USA

[10] McMaster Univ, Hamilton, ON, Canada

[11] British Heart Fdn, Glasgow Cardiovasc Rsch Cntr, Glasgow, Lanark, Scotland

[12] Bristol Myers Squibb Co, Princeton, NJ USA

[13] Sanofi Aventis, Bridgeport, CT USA

[14] San Francisco VA Med Ctr, San Francisco, CA USA

[15] Univ Calif San Francisco, San Francisco, CA USA

来源：

CIRCULATION | 2009年 / 120卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S757 / S758

页数：2

共 50 条

[1] Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
Haass, Markus
Kitzman, Dalane W.
Anand, Inder S.
Miller, Alan
Zile, Michael R.
Massie, Barry M.
Carson, Peter E.
CIRCULATION-HEART FAILURE, 2011, 4 (03) : 324 - 331
[2] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
Lam, Carolyn S. P.
Carson, Peter E.
Anand, Inder S.
Rector, Thomas S.
Kuskowski, Michael
Komajda, Michel
McKelvie, Robert S.
McMurray, John J.
Zile, Michael R.
Massie, Barry M.
Kitzman, Dalane W.
CIRCULATION-HEART FAILURE, 2012, 5 (05) : 571 - 578
[3] Relationship between pulse pressure and mortality in heart failure with preserved ejection fraction in the I-Preserve Trial
Pozzi, A.
Jhund, P. S.
Carson, P. E.
Komajda, M. R.
Mckelvie, M. R.
Zile, M. R.
Mcmurray, J. J. V.
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 277 - 278
[4] Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
Kristensen, Soren L.
Mogensen, Ulrik M.
Jhund, Pardeep S.
Petrie, Mark C.
Preiss, David
Win, Sithu
Kober, Lars
McKelvie, Robert S.
Zile, Michael R.
Anand, Inder S.
Komajda, Michel
Gottdiener, John S.
Carson, Peter E.
McMurray, John J. V.
CIRCULATION, 2017, 135 (08) : 724 - +
[5] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients with Heart Failure and Preserved Ejection Fraction: The I-PRESERVE Trial
Lam, Carolyn S.
Anand, Inder S.
Carson, Peter E.
Massie, Barry M.
Rector, Thomas S.
Kuskowski, Michael
McKelvie, Robert S.
Zile, Michael R.
McMurray, John J.
Komajda, Michel
Kitzman, Dalane W.
CIRCULATION, 2011, 124 (21)
[6] Mode of death in patients with heart failure and a preserved ejection fraction: results from irbesartan heart failure with preserved ejection fraction study (I-Preserve) trial
Zile, M. R.
Gaasch, W. H.
Anand, I.
Haass, M.
Little, W. C.
Miller, A.
Lopez-Sendon, J.
Teerlink, J. R.
White, M.
Carson, P. E.
EUROPEAN HEART JOURNAL, 2009, 30 : 867 - 867
[7] Predictors of outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in heart failure with preserved ejection fraction trial (I-PRESERVE)
Carson, P. E.
Komajda, M.
Zile, M. R.
Mckelvie, R.
Mcmurray, J. J.
Hetzel, S.
Demets, D.
Staiger, C.
Ptaszynska, A.
Massie, B. M.
EUROPEAN HEART JOURNAL, 2009, 30 : 865 - 865
[8] Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial
Zile, Michael R.
Gaasch, William H.
Anand, Inder S.
Haass, Markus
Little, William C.
Miller, Alan B.
Lopez-Sendon, Jose
Teerlink, John R.
White, Michel
McMurray, John J.
Komajda, Michel
McKelvie, Robert
Ptaszynska, Agata
Hetzel, Scott J.
Massie, Barry M.
Carson, Peter E.
CIRCULATION, 2010, 121 (12) : 1393 - 1405
[9] Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial
McMurray, John J. V.
Carson, Peter E.
Komajda, Michel
McKelvie, Robert
Zile, Michael R.
Ptaszynska, Agata
Staiger, Christoph
Donovan, J. Mark
Massie, Barry M.
EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (02) : 149 - 156
[10] BASELINE SYSTOLIC BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION - RESULTS FROM THE I-PRESERVE TRIAL
Anand, Inderjit S.
Hetzel, Scott J.
Miller, Alan B.
Carson, Peter E.
Gaasch, William H.
Haass, Markus
Little, William C.
Lopez-Sendon, Jose
Massie, Barry M.
McMurray, John J.
Ptaszynska, Agata
Teerlink, John R.
White, Michel
Zile, Michael R.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)

← 1 2 3 4 5 →